Solabia acquired a majority stake in BioActor B.V. 

This strategic investment will allow Solabia to benefit from a wider range of ingredients and from BioActor’s expertise, strengthening its nutrition division. This  partnership will also support BioActor’s continued focus on R&D and product development, as well as the expansion of its production capabilities, enabling the company to serve the increasing global demand for its products, according to a press release. BioActor will become a centre of excellence for innovation and clinical research within Solabia’s nutrition division. The deal will allow both companies to benefit from the combined network and expertise, as well as to access new marketing channels and an expanded customer base.

ADM opened a new production facility in Valencia, Spain.

The new facility will help the company meet rising global demand for probiotics, postbiotics, and more. The facility represents an investment north of $30 million and a more than five-fold increase in ADM’s production capacity, increasing it to 50 metric tons per year. It will allow ADM to supply growing markets for probiotics and postbiotics in the U.S., Asia-Pacific, and Europe and will help the company fulfill its expansion strategy in the health and well-being sector, according to the announcement. The site will produce ADM’s  probiotic BPL1 and the heat-treated BPL1 postbiotic, as well as other ADM proprietary strains.


Carman Ranch has been verified as “Regenified Tier 3”  

Regenified shared the news, citing Carman Ranch for its regenerative ranching practices and resulting improved ecosystem function. Carman Ranch is eligible to use the Regenified seal on their grass-fed beef products and in their marketing and consumer education efforts.


ByHeart acquired an additional manufacturing facility

This will enable the next-generation baby nutrition company to scale production capacity of its  infant formula and increase domestic infant formula supply. Recognizing that the formula industry, which historically has been dominated by three players who control 90% of the market, was in need of change, ByHeart founders Ron Belldegrun and Mia Funt began working with DairiConcepts' FDA-registered facility in Allerton, Iowa, in 2018 to proactively build redundancy into their production ecosystem.

Subscribe to In The Know newsletters to stay informed! 

Don't miss the latest: